UBS Group’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
UBS Group's REVS Position: Q2 2026 in Review
UBS Group sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 3,651 shares — an estimated $104K sold.
UBS Group first reported a position in REVS in Q4 2021 and held it in 11 quarters. The position peaked at $104K in Q1 2026. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- UBS Group reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 3,651 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $104K.
- UBS Group first reported a position in Columbia Research Enhanced Value ETF in Q4 2021 and held it in 11 quarters.
- UBS Group's Columbia Research Enhanced Value ETF position peaked at $104K in Q1 2026.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.